专利信息

首页 1 2 3 4 5 6 下页尾页共 720 条记录, 当前第1/72页。

专利标题：Novel ticagrelor co - crystal

专利权人：ASTRAZENECA AB;

The present invention relates to a novel co-crystal of the compound of formula (I): wherein the co-former molecule is acetyl salicylic acid, to processes for the preparation of the co-crystal, to pharmaceutical compositions containing the co-crystal, to the use of such a co-crystal in the manufacture of a medicament for use in the prevention of arterial thrombotic complications in patients with coronary artery, cerebrovascular or peripheral vascular disease and to methods of treating such diseas...

专利标题：Therapeutic treatment

专利权人：ASTRAZENECA AB;

专利标题：(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives

专利权人：ASTRAZENECA AB;

The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain.

专利标题：Combination treatment

专利权人：ASTRAZENECA AB;

The present invention relates to a combination comprising AZD5363, or a pharmaceutically acceptable salt thereof, and at least one androgen receptor signalling modulator selected from MDV-3 100 (also known as enzalutamide), AZD3514, abiraterone 5 (or an ester prodrug thereof: e.g. abiraterone acetate), and bicalutamide

专利标题：Form of s-omeprazole

专利权人：ASTRAZENECA AB;

The present invention relates to a novel form of the (-)-enantiomer of 5-methoxy-2-[[(4-methoxy-35-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole i.e. S-omeprazole. More specifically it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore the present invention also relates to new ...

专利标题：Combination treatment

专利权人：ASTRAZENECA AB;

104216-WO-PCT/O The present invention relates to a combination comprising AZD5363, or a pharmaceutically acceptable salt thereof, and at least one androgen receptor signalling modulator selected from MDV-3 100 (also known as enzalutamide), AZD3514, abiraterone 5 (or an ester prodrug thereof: eg. abiraterone acetate), and bicalutanide

专利标题：Therapeutic treatment

专利权人：ASTRAZENECA AB;

The present invention relates to a combination comprising (5)-4-amino-N-(1-(4- chlorophenyl)-3 -hydroxypropyl)-1-(7H-pyrrolo [2,3 -d]pyrimidin-4-yl)piperidine-4- carboxamide, or a pharmaceutically acceptable salt thereof, hereafter "Compound (I)", and a taxane. Taxanes include established cancer drugs such as docetaxel (Taxotere

专利标题：HETEROCYCLIC COMPOUNDS AS CCR2b ANTAGONISTS

专利权人：ASTRAZENECA AB;

Compounds of formula (I) Q-L-W-C(=X)-Z-P wherein Q is a secondary or tertiary amine of the formula N(R1 )(R2)

专利标题：Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid

专利权人：ASTRAZENECA AB;

专利标题：Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor

专利权人：ASTRAZENECA AB;

当前查询条件: [IPC] 包含 'A' AND [专利权人] 包含 'ASTRAZENECA AB'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. AU2012264432A1	2014/1/9	AU20120264432	2012/5/31
专利标题：Novel ticagrelor co - crystal 专利权人：ASTRAZENECA AB; The present invention relates to a novel co-crystal of the compound of formula (I): wherein the co-former molecule is acetyl salicylic acid, to processes for the preparation of the co-crystal, to pharmaceutical compositions containing the co-crystal, to the use of such a co-crystal in the manufacture of a medicament for use in the prevention of arterial thrombotic complications in patients with coronary artery, cerebrovascular or peripheral vascular disease and to methods of treating such diseas...

2. CN103442708A	2013/12/11	CN2012816297	2012/4/2
专利标题：Therapeutic treatment 专利权人：ASTRAZENECA AB;

3. AU2009327575B2	2013/7/4
专利标题：(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives 专利权人：ASTRAZENECA AB; The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain.

4. AU2012321110A1	2013/6/20	AU20120321110	2012/11/30
专利标题：Combination treatment 专利权人：ASTRAZENECA AB; The present invention relates to a combination comprising AZD5363, or a pharmaceutically acceptable salt thereof, and at least one androgen receptor signalling modulator selected from MDV-3 100 (also known as enzalutamide), AZD3514, abiraterone 5 (or an ester prodrug thereof: e.g. abiraterone acetate), and bicalutamide

5. US8466175B2	2013/6/18	US13/298373	2011/11/17
专利标题：Form of s-omeprazole 专利权人：ASTRAZENECA AB; The present invention relates to a novel form of the (-)-enantiomer of 5-methoxy-2-[[(4-methoxy-35-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole i.e. S-omeprazole. More specifically it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore the present invention also relates to new ...

6. AU2013205648A1	2013/6/13	AU20130205648	2012/11/30
专利标题：Combination treatment 专利权人：ASTRAZENECA AB; 104216-WO-PCT/O The present invention relates to a combination comprising AZD5363, or a pharmaceutically acceptable salt thereof, and at least one androgen receptor signalling modulator selected from MDV-3 100 (also known as enzalutamide), AZD3514, abiraterone 5 (or an ester prodrug thereof: eg. abiraterone acetate), and bicalutanide

7. AU2012235902A1	2013/5/2	AU20120235902	2012/4/2
专利标题：Therapeutic treatment 专利权人：ASTRAZENECA AB; The present invention relates to a combination comprising (5)-4-amino-N-(1-(4- chlorophenyl)-3 -hydroxypropyl)-1-(7H-pyrrolo [2,3 -d]pyrimidin-4-yl)piperidine-4- carboxamide, or a pharmaceutically acceptable salt thereof, hereafter "Compound (I)", and a taxane. Taxanes include established cancer drugs such as docetaxel (Taxotere

8. AU2013200955A1	2013/3/7	AU20130200955	2013/2/18
专利标题：HETEROCYCLIC COMPOUNDS AS CCR2b ANTAGONISTS 专利权人：ASTRAZENECA AB; Compounds of formula (I) Q-L-W-C(=X)-Z-P wherein Q is a secondary or tertiary amine of the formula N(R1 )(R2)

9. EP1957081A4	2013/1/2
专利标题：Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid 专利权人：ASTRAZENECA AB;

10. CN102770434A	2012/11/7	CN2010863050	2010/12/3
专利标题：Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor 专利权人：ASTRAZENECA AB;

下载范围

下载内容